Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

What are the prognostic factors for survival in patients with metastatic renal cell carcinoma?

Nature Clinical Practice Oncology volume 2, pages 292–293 (2005)Cite this article

boxed-textMekhail TM et al. (2005) Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma. J Clin Oncol 23: 832–841

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Motzer RJ et al. (2002) Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. J Clin Oncol 20: 289–296

    Article  CAS  Google Scholar 

  2. Rini BI and Small EJ (2005) Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma. J Clin Oncol 23: 1028–1043

    Article  CAS  Google Scholar 

  3. Bukowski RM et al. (2004) Prognostic factors in patients with advanced renal cell carcinoma: development of an international kidney cancer working group. Clin Cancer Res 10: 6310S–6314S

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Assistant Professor of Medicine at the University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA

    Brian I Rini

Authors
  1. Brian I Rini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brian I Rini.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Glossary

COX MULTIVARIATE MODEL

Statistical regression technique which takes into account the time interval to an outcome in relation to baseline characteristics (of a patient)

EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS (ECOG PS)

A 0 (fully active) to 5 (dead) scoring system to assess the wellbeing of cancer patients and their ability to perform ordinary tasks

SURVIVAL

Defined as the time from treatment initiation to the date of death or last follow-up

VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)

A soluble factor that stimulates vascular permeability and blood vessel growth

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rini, B. What are the prognostic factors for survival in patients with metastatic renal cell carcinoma?. Nat Rev Clin Oncol 2, 292–293 (2005). https://doi.org/10.1038/ncponc0180

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0180

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing